ArticlePharmacoEconomics2010

Cost effectiveness of darunavir/ritonavir 600/100 mg bid in protease inhibitor-experienced, HIV-1-infected adults in Belgium, Italy, Sweden and the UK.

Karen Moeremans et al.PubMed ↗Publisher ↗

No numbers read from the abstract.